SCHEMBL5961764

SCHEMBL5961764

C=C(F)C(=O)OCCOC(=O)c1cc(OC(=O)c2ccc(C)cc2)ccc1OC(=O)c1ccc(OCCCC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.45
KMT2A Q03164 4/20 0.45
LMNA P02545 3/20 0.43
NPC1 O15118 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PRSS1 P07477 1/20 0.41
ACR P10323 1/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.41
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5961866 0.97 NPC1 (0.47) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL12731177 0.96 KMT2A (0.47) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL5961768 0.93 LMNA (0.42) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL12731196 0.93 NPC1 (0.51) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL5961869 0.89 MAPT (0.39) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL17229438 0.89 POLB (0.51) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL5961765 0.87 NPC1 (0.45) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL12731216 0.87 MAPT (0.44) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL5961772 0.87 MAPT (0.38) MAPTKMT2ALMNANPC1CYP1A2
SCHEMBL5961855 0.86 MAPT (0.50) MAPTKMT2ALMNANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168734-B2 Lateral alpha-substituted acrylate compound and polymer thereof JNC CORPORATION (JP) 2012-05-01 US disclosed
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF CHISSO CORPORATION (JP) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144293-A1 LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF LEF1, AFF1, CNKSR1 MAPT 3921/4885KMT2A 1856/4885LMNA 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.